Adaptimmune Therapeutics plc (ADAPY)
OTCMKTS · Delayed Price · Currency is USD
0.0280
0.00 (0.00%)
Feb 5, 2026, 4:00 PM EST
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of $7.95 million as of February 6, 2026. Its market cap has decreased by -94.59% in one year.
Market Cap
7.95M
Enterprise Value
30.57M
Revenue
65.09M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.22B to 7.95M, a decrease of -99.35%. That is a compound annual growth rate of -37.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 6.89M | - |
| Dec 31, 2025 | 6.89M | -95.00% |
| Dec 31, 2024 | 137.84M | -23.47% |
| Dec 29, 2023 | 180.11M | -24.70% |
| Dec 30, 2022 | 239.19M | -59.17% |
| Dec 31, 2021 | 585.77M | -29.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inhibitor Therapeutics | 10.39M |
| AccuStem Sciences | 9.35M |
| Biomind Labs | 8.84M |
| Curative Biotechnology | 7.94M |
| NKGen Biotech | 7.84M |
| Synlogic | 7.43M |
| Brainstorm Cell Therapeutics | 6.62M |
| Orgenesis | 5.90M |